Alere Inc

Latest stories

1h
Business Wire
Brower Piven Commences an Investigation into the Proposed Sale of Alere, Inc. and Encourages Investors to Contact the Firm for Additional InformationSTEVENSON, Md.--(BUSINESS WIRE)--The securities litigation law firm of Brower P
Brower Piven Commences an Investigation into the Proposed Sale of Alere, Inc. and Encourages Investors to Contact the Firm for Additional Information
Business Wire / Posted an hour ago
STEVENSON, Md.--(BUSINESS WIRE)--The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of... Read more
3d
Business Wire
Levi & Korsinsky, LLP Notifies Shareholders of Alere Inc. of an Investigation Regarding the Fairness of the Sale of the Company to Abbott Laboratories -- ALRNEW YORK--(BUSINESS WIRE)--The following statement is being issued by Levi & Ko
Levi & Korsinsky, LLP Notifies Shareholders of Alere Inc. of an Investigation Regarding the Fairness of the Sale of the Company to Abbott Laboratories -- ALR
Business Wire / Posted 3 days ago
NEW YORK--(BUSINESS WIRE)--The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Alere Inc. stock prior to February 1, 2016. You are hereby notified that Levi & Korsinsky, LLP has commenced an... Read more
7 related stories
4d
Business Wire
The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Alere Inc. Concerning the Sale of the Company to Abbott LaboratoriesNEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong are investigating po
The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Alere Inc. Concerning the Sale of the Company to Abbott Laboratories
Business Wire / Posted 4 days ago
NEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Alere Inc. (NYSE: ALR) (“Alere” or “the Company”) in connection with the sale of the Company to Abbott Laboratories (NYSE:... Read more
7d
The Globe and Mail
Calendar: What investors need to know for the week aheadA daily rundown of the economic reports and corporate earnings that will be gra
Calendar: What investors need to know for the week ahead
The Globe and Mail / Posted 7 days ago
A daily rundown of the economic reports and corporate earnings that will be grabbing the market's attention in the week ahead. China markets closed all week for a holiday Monday February 8 Japan releases current account surplus. India releases... Read more
8d
PharmaceuticalOnline
Abbott To Acquire Alere Becoming Leader In Point Of Care Testing And Significantly Advancing Global Diagnostics PresenceAbbott Gains Leadership In The $5.5 Billion Point Of Care Segment, Broadens Dia
Abbott To Acquire Alere Becoming Leader In Point Of Care Testing And Significantly Advancing Global Diagnostics Presence
PharmaceuticalOnline / Posted 8 days ago
Abbott Gains Leadership In The $5.5 Billion Point Of Care Segment, Broadens Diagnostics Footprint And Enhances Access To Fast-Growing Diagnostics Channels Transaction expected to be immediately accretive to Abbott's ongoing earnings per share upon... Read more
10d
Providence Business News
Health-care costs continue driving deals for med-tech companiesMINNEAPOLIS - Medical-device companies, under pressure from hospitals and healt
Health-care costs continue driving deals for med-tech companies
Providence Business News / Posted 10 days ago
MINNEAPOLIS - Medical-device companies, under pressure from hospitals and health insurers to keep expenses down, are capitalizing on strong cash flows and the stumbling stock market to beef up cost-controlling technologies that may be critical to... Read more
10d
The Columbus Dispatch
Abbott to buy medical-test provider Alere Abbott Laboratories will buy Alere for $4.8 billion as it tries to expand its
Abbott to buy medical-test provider Alere
The Columbus Dispatch / Posted 10 days ago
Abbott Laboratories will buy Alere for $4.8 billion as it tries to expand its medical-testing business. Infant formula and nutritional beverages are currently Abbott’s biggest business, with its... Read more
9 related stories
10d
Weekly Times
Abbott to buy medical test provider Alere Abbott Laboratories will buy Alere for $US4.8 billion ($A6.76 billion) as it
Abbott to buy medical test provider Alere
Weekly Times / Posted 10 days ago
Abbott Laboratories will buy Alere for $US4.8 billion ($A6.76 billion) as it tries to expand its medical-testing business. The deal is worth $US5.8 billion when restricted stock, stock options and preferred... Read more
9 related stories
10d
TribLIVE
Roundup: Dominion Resources buying Questar for about $4.4 billion; New federal coal mine dust rules taking effect; more | TribLIVE.com Neighborhoods Roundup: Dominion Resources buying Questar for
Roundup: Dominion Resources buying Questar for about $4.4 billion; New federal coal mine dust rules taking effect; more
TribLIVE / Posted 10 days ago
| TribLIVE.com Neighborhoods Roundup: Dominion Resources buying Questar for about $4.4 billion; New federal coal mine dust rules... Read more
10d
Boston Herald
The TickerWaltham’s Alere bought by Abbott for $4.8BAbbott Laboratories will buy Waltham-
The Ticker
Boston Herald / Posted 10 days ago
Waltham’s Alere bought by Abbott for $4.8BAbbott Laboratories will buy Waltham-based Alere for $4.8 billion as it tries to expand its medical-testing business. The deal is worth $5.8 billion when restricted stock, stock options and preferred shares... Read more
10d
WWLP Springfield
Abbott to buy medical test provider AlereNEW YORK (AP) — Abbott Laboratories will buy Alere for $4.8 billion as it tries
Abbott to buy medical test provider Alere
WWLP Springfield / Posted 10 days ago
NEW YORK (AP) — Abbott Laboratories will buy Alere for $4.8 billion as it tries to expand its medical-testing business. The deal is worth $5.8 billion when restricted stock, stock options and preferred shares are included, the company said... Read more
9 related stories
11d
The Courier Mail
Abbott to buy medical test provider Alere Abbott Laboratories will buy Alere for $US4.8 billion ($A6.76 billion) as it
Abbott to buy medical test provider Alere
The Courier Mail / Posted 11 days ago
Abbott Laboratories will buy Alere for $US4.8 billion ($A6.76 billion) as it tries to expand its medical-testing business. The deal is worth $US5.8 billion when restricted stock, stock options and preferred... Read more
9 related stories
11d
TheStreet.com
Alere's Stock Spikes Following News of Its Impending Buy by Abbott Abbott Laboratories announced on Monday, Jan. 1, a $7.9 billion deal to buy A
Alere's Stock Spikes Following News of Its Impending Buy by Abbott
TheStreet.com / Posted 11 days ago
Abbott Laboratories announced on Monday, Jan. 1, a $7.9 billion deal to buy Alere Inc., a provider of point-of-care testing that has spent the past several months streamlining... Read more
11d
Your Hometown Lima Stations
Abbott to buy medical test provider AlereNEW YORK (AP) - Abbott Laboratories will buy Alere for $4.8 billion as it tries
Abbott to buy medical test provider Alere
Your Hometown Lima Stations / Posted 11 days ago
NEW YORK (AP) - Abbott Laboratories will buy Alere for $4.8 billion as it tries to expand its medical-testing business. The deal is worth $5.8 billion when restricted stock, stock options and preferred shares are included, the company said... Read more
9 related stories
11d
Channel NewsAsia
Abbott Labs to buy diagnostics company Alere for US$5.8 billionREUTERS: Abbott Laboratories said it would buy Alere Inc for US$5.8 billion to
Abbott Labs to buy diagnostics company Alere for US$5.8 billion
Channel NewsAsia / Posted 11 days ago
REUTERS: Abbott Laboratories said it would buy Alere Inc for US$5.8 billion to become a leader in point-of-care testing, a fast-growing market as physicians increasingly adopt rapid tests that speed up treatment. Point-of-care tests provide results... Read more
4 related stories
11d
FOX Business
Alere Shares Surge Almost 50% On News Of Abbott TakeoverAlere Inc. shares surged almost 50% in premarket trade Monday, after Abbott Lab
Alere Shares Surge Almost 50% On News Of Abbott Takeover
FOX Business / Posted 11 days ago
Alere Inc. shares surged almost 50% in premarket trade Monday, after Abbott Laboratories said it has agreed to buy the diagnostics company in a deal with an equity value of $5.8 billion. Abbott Labs said it will pay $56 per Alere share, or a 50%... Read more
6 related stories
11d
FOX Business
Alere Shares Surge Almost 50% On News Of Abbott TakeoverAlere Inc. shares surged almost 50% in premarket trade Monday, after Abbott Lab
Alere Shares Surge Almost 50% On News Of Abbott Takeover
FOX Business / Posted 11 days ago
Alere Inc. shares surged almost 50% in premarket trade Monday, after Abbott Laboratories said it has agreed to buy the diagnostics company in a deal with an equity value of $5.8 billion. Abbott Labs said it will pay $56 per Alere share, or a 50%... Read more
6 related stories
11d
Your Hometown Lima Stations
Baby formula maker Abbott to buy medical test provider AlereNEW YORK (AP) - Abbott Laboratories will buy Alere for $4.8 billion as it tries
Baby formula maker Abbott to buy medical test provider Alere
Your Hometown Lima Stations / Posted 11 days ago
NEW YORK (AP) - Abbott Laboratories will buy Alere for $4.8 billion as it tries to expand its medical-testing business. Alere Inc., based in Waltham, Massachusetts, makes tests used to diagnosis the flu, HIV, malaria and several other diseases that... Read more
9 related stories
11d
Market Watch
Abbott Labs to buy Alere for $5.8 billionAbbott Laboratories agreed to acquire diagnostic-test company Alere Inc. for $5
Abbott Labs to buy Alere for $5.8 billion
Market Watch / Posted 11 days ago
Abbott Laboratories agreed to acquire diagnostic-test company Alere Inc. for $5.8 billion, a deal Abbott expects will make it a leading provider of point-of-care testing. Following the deal, Abbott said its total diagnostics sales would exceed $7... Read more
4 related stories
11d
Denver Post
Drugmaker Abbott to buy medical test maker AlereNEW YORK (AP) — Abbott Laboratories said Monday that it is buying Alere for $4.
Drugmaker Abbott to buy medical test maker Alere
Denver Post / Posted 11 days ago
NEW YORK (AP) — Abbott Laboratories said Monday that it is buying Alere for $4.8 billion as it tries to expand its medical-testing business. Alere makes tests used to diagnosis the flu, HIV, malaria and several other diseases. Abbott makes drugs,... Read more
9 related stories
11d
Your Hometown Lima Stations
Drugmaker Abbott to buy medical test maker AlereNEW YORK (AP) - Abbott Laboratories said Monday that it is buying Alere for $4.
Drugmaker Abbott to buy medical test maker Alere
Your Hometown Lima Stations / Posted 11 days ago
NEW YORK (AP) - Abbott Laboratories said Monday that it is buying Alere for $4.8 billion as it tries to expand its medical-testing business. Alere makes tests used to diagnosis the flu, HIV, malaria and several other diseases. Abbott makes drugs,... Read more
9 related stories
11d
KOB 4 Albuquerque
Abbott to buy Alere for $5.8 billionNEW YORK (AP) — Abbott Laboratories is buying Alere for $5.8 billion as it trie
Abbott to buy Alere for $5.8 billion
KOB 4 Albuquerque / Posted 11 days ago
NEW YORK (AP) — Abbott Laboratories is buying Alere for $5.8 billion as it tries to expand its medical diagnostics business. Alere makes tests used to diagnosis the flu, HIV, malaria and several other diseases. Abbott makes drugs, infant formula and... Read more
9 related stories
11d
Your Hometown Lima Stations
Abbott to buy Alere for $5.8 billionNEW YORK (AP) - Abbott Laboratories is buying Alere for $5.8 billion as it trie
Abbott to buy Alere for $5.8 billion
Your Hometown Lima Stations / Posted 11 days ago
NEW YORK (AP) - Abbott Laboratories is buying Alere for $5.8 billion as it tries to expand its medical diagnostics business. Alere makes tests used to diagnosis the flu, HIV, malaria and several other diseases. Abbott makes drugs, infant formula and... Read more
9 related stories
11d
Market Watch
Alere shares surge almost 50% on news of Abbott takeoverAlere Inc. shares ALR, +1.83% surged almost 50% in premarket trade Monday, afte
Alere shares surge almost 50% on news of Abbott takeover
Market Watch / Posted 11 days ago
Alere Inc. shares ALR, +1.83% surged almost 50% in premarket trade Monday, after Abbott Laboratories ABT, +3.11% said it has agreed to buy the diagnostics company in a deal with an equity value of $5.8 billion. Abbott Labs said it will pay $56 per... Read more
6 related stories
17d
Business Wire
Global Medical Laboratory Services Strategies, Trends and Forecasts 2016 to 2019A market that just keeps on growing. Clinical laboratory testing is positioned
Global Medical Laboratory Services Strategies, Trends and Forecasts 2016 to 2019
Business Wire / Posted 17 days ago
A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations. Trends like: -... Read more
2 related stories
21d
Crain's Chicago Business
Drug industry to fight superbugs together with governments(AP) — Dozens of makers of medicines and diagnostic tests have joined together
Drug industry to fight superbugs together with governments
Crain's Chicago Business / Posted 21 days ago
(AP) — Dozens of makers of medicines and diagnostic tests have joined together in an unprecedented effort to tackle "superbugs" — infections that increasingly don't respond to drugs and threaten millions of people in countries rich and... Read more
109 related stories
22d
Manila Bulletin
Drug industry to fight superbugs together with governments TRENTON, New Jersey — Dozens of makers of medicines and diagnostic tests have
Drug industry to fight superbugs together with governments
Manila Bulletin / Posted 22 days ago
TRENTON, New Jersey — Dozens of makers of medicines and diagnostic tests have joined together in an unprecedented effort to tackle “superbugs” — infections that increasingly don’t respond to... Read more
109 related stories
22d
Daily Herald
Drug industry to fight superbugs together with governmentsTRENTON, N.J. -- Dozens of makers of medicines and diagnostic tests have joined
Drug industry to fight superbugs together with governments
Daily Herald / Posted 22 days ago
TRENTON, N.J. -- Dozens of makers of medicines and diagnostic tests have joined together in an unprecedented effort to tackle "superbugs" - infections that increasingly don't respond to drugs and threaten millions of people in countries rich and... Read more
109 related stories
22d
ABC News
Drug Industry to Fight Superbugs Together With GovernmentsDozens of makers of medicines and diagnostic tests have joined together in an u
Drug Industry to Fight Superbugs Together With Governments
ABC News / Posted 22 days ago
Dozens of makers of medicines and diagnostic tests have joined together in an unprecedented effort to tackle "superbugs" — infections that increasingly don't respond to drugs and threaten millions of people in countries rich and poor. Altogether, 74... Read more
109 related stories
22d
Hawaii News Now
Drug industry to fight superbugs together with governmentsTRENTON, N.J. (AP) - Dozens of makers of medicines and diagnostic tests have jo
Drug industry to fight superbugs together with governments
Hawaii News Now / Posted 22 days ago
TRENTON, N.J. (AP) - Dozens of makers of medicines and diagnostic tests have joined together in an unprecedented effort to tackle "superbugs" - infections that increasingly don't respond to drugs and threaten millions of people in countries rich and... Read more
109 related stories
22d
Your Hometown Lima Stations
Drug industry to fight superbugs together with governmentsTRENTON, N.J. (AP) - Dozens of makers of medicines and diagnostic tests have jo
Drug industry to fight superbugs together with governments
Your Hometown Lima Stations / Posted 22 days ago
TRENTON, N.J. (AP) - Dozens of makers of medicines and diagnostic tests have joined together in an unprecedented effort to tackle "superbugs" - infections that increasingly don't respond to drugs and threaten millions of people in countries rich and... Read more
109 related stories
22d
KTEN North Texas & Southeastern Oklahoma
Drug industry to fight superbugs together with governmentsTRENTON, N.J. (AP) - Dozens of makers of medicines and diagnostic tests have jo
Drug industry to fight superbugs together with governments
KTEN North Texas & Southeastern Oklahoma / Posted 22 days ago
TRENTON, N.J. (AP) - Dozens of makers of medicines and diagnostic tests have joined together in an unprecedented effort to tackle "superbugs" - infections that increasingly don't respond to drugs and threaten millions of people in countries rich and... Read more
2 related stories
28d
Business Wire
Asia-Pacific Infectious Diagnostics Market Outlook 2015"Asia-Pacific Infectious Diagnostics Market Outlook to 2021", provides key mark
Asia-Pacific Infectious Diagnostics Market Outlook 2015
Business Wire / Posted 28 days ago
"Asia-Pacific Infectious Diagnostics Market Outlook to 2021", provides key market data on the Asia-Pacific Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses,... Read more
m
Market Watch
Alere cuts its revenue outlook on mild flu seasonAlere Inc. said Monday its fourth quarter revenue would miss estimates as it fa
Alere cuts its revenue outlook on mild flu season
Market Watch / Posted 1 months ago
Alere Inc. said Monday its fourth quarter revenue would miss estimates as it faces foreign exchange headwinds and a quiet North American flu season. The diagnostics company now estimates revenue of $630 million, below its previous estimate of $640... Read more
m
Business Wire
Russia Infectious Diagnostics Market Outlook to 2021"" provides key market data on the Russia Infectious Diagnostics market. The re
Russia Infectious Diagnostics Market Outlook to 2021
Business Wire / Posted 1 months ago
"" provides key market data on the Russia Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious... Read more
12 related stories

People in this news